Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
1.335
-0.035 (-2.55%)
At close: Apr 28, 2026, 4:00 PM EDT
1.340
+0.005 (0.37%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Health Catalyst Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Health Catalyst stock have an average target of 2.53, with a low estimate of 1.00 and a high estimate of 4.00. The average target predicts an increase of 89.51% from the current stock price of 1.34.
Analyst Consensus: Hold
* Price targets were last updated on Mar 18, 2026.
Analyst Ratings
The average analyst rating for Health Catalyst stock from 10 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 8 | 8 | 8 | 8 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $5 → $1 | Buy → Hold | Downgrades | $5 → $1 | -25.09% | Mar 18, 2026 |
| Citigroup | Citigroup | Hold Maintains $2.75 → $1.75 | Hold | Maintains | $2.75 → $1.75 | +31.09% | Mar 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $5 → $2 | Strong Buy | Maintains | $5 → $2 | +49.81% | Mar 13, 2026 |
| Stephens & Co. | Stephens & Co. | Hold Maintains $3.5 → $2 | Hold | Maintains | $3.5 → $2 | +49.81% | Mar 13, 2026 |
| Stifel | Stifel | Hold Maintains $3.75 → $2 | Hold | Maintains | $3.75 → $2 | +49.81% | Mar 13, 2026 |
Financial Forecast
Revenue This Year
285.84M
from 311.14M
Decreased by -8.13%
Revenue Next Year
285.41M
from 285.84M
Decreased by -0.15%
EPS This Year
0.14
from -2.55
EPS Next Year
0.16
from 0.14
Increased by 12.19%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 307.3M | 317.1M | |
| Avg | 285.8M | 285.4M | |
| Low | 261.8M | 236.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.2% | 10.9% | |
| Avg | -8.1% | -0.2% | |
| Low | -15.9% | -17.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.40 | 0.40 | |
| Avg | 0.14 | 0.16 | |
| Low | -0.02 | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 186.2% | |
| Avg | - | 12.2% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.